OMRF has received a pair of grants totaling almost $600,000 from the Lupus Research Alliance.
According to the Lupus Foundation of America, more than 1.5 million Americans suffer from the disease.
A recent OMRF study is potentially paving the way for better preventive treatment options for African American patients.
Multiple studies have show the drug is not effective at treating COVID-19, and in some cases can even cause heart problems.
James received the award for her contributions to understanding systemic autoimmune diseases such as lupus and rheumatoid arthritis.
The prospect that hydroxychloroquine might be effective for treating the coronavirus has raised hopes, but it’s also created a potential crisis.